C07J 9/005
Containing a carboxylic function directly attached or attached by a chain containing
Official title: {containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton}
C07J9/005 (Containing a carboxylic function directly attached or attached by a chain containing) appears on 462 US grants and 451 published applications in this corpus.
Search patents in C07J- Granted patents
- 462
- Published applications
- 451
- Assignees
- 247
- Inventors
- 1,031
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 6 | 0 |
| 1978 | 6 | 0 |
| 1979 | 8 | 0 |
| 1980 | 14 | 0 |
| 1981 | 12 | 0 |
| 1982 | 10 | 0 |
| 1983 | 3 | 0 |
| 1984 | 12 | 0 |
| 1985 | 12 | 0 |
| 1986 | 5 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 5 | 0 |
| 1990 | 8 | 0 |
| 1991 | 8 | 0 |
| 1992 | 8 | 0 |
| 1993 | 5 | 0 |
| 1994 | 5 | 0 |
| 1995 | 6 | 0 |
| 1996 | 11 | 0 |
| 1997 | 14 | 0 |
| 1998 | 9 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 1 |
| 2002 | 7 | 3 |
| 2003 | 0 | 2 |
| 2004 | 1 | 0 |
| 2005 | 0 | 5 |
| 2006 | 4 | 4 |
| 2007 | 0 | 5 |
| 2008 | 2 | 7 |
| 2009 | 1 | 5 |
| 2010 | 5 | 9 |
| 2011 | 5 | 10 |
| 2012 | 2 | 11 |
| 2013 | 9 | 16 |
| 2014 | 6 | 14 |
| 2015 | 10 | 19 |
| 2016 | 18 | 41 |
| 2017 | 22 | 35 |
| 2018 | 19 | 36 |
| 2019 | 32 | 38 |
| 2020 | 39 | 48 |
| 2021 | 40 | 38 |
| 2022 | 17 | 27 |
| 2023 | 12 | 21 |
| 2024 | 12 | 18 |
| 2025 | 12 | 25 |
| 2026 | 4 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof6 Oct 2026US 12,753,204 B2Enanta Pharmaceuticals, Inc.
- Neuroactive steroids and methods of use thereof5 May 2026US 12,617,814 B2Sage Therapeutics, Inc.
- Small molecule modulators of gut bacterial bile acid metabolism17 Mar 2026US 12,577,273 B2President and Fellows of Harvard College
- Pharmaceutical composition for treating fatty liver disease13 Jan 2026US 12,521,375 B2Shionogi & Co., Ltd.
- Human aminosterol ENT-03 compounds, related compositions comprising the same, and methods of using the same23 Dec 2025US 12,503,485 B2Enterin, Inc.
- Lipid nanoparticle compositions and uses thereof1 Oct 2026US 2026/0294935 A1Beijing Jitai Life Science Ltd
- Pharmaceuticl compositions comprising bile acid compounds for oral delivery of therapeutic peptides1 Oct 2026US 2026/0294936 A1Waterstone Pharmaceuticals(Wuhan) Co., Ltd.
- Crystalline forms of a farnesoid x receptor agonist17 Sep 2026US 2026/0274886 A1Alfasigma S.P.A.
- Dexamethasone prodrug compositions and uses thereof20 Aug 2026US 2026/0240776 A1Ripple Therapeutics Corporation
- Preparation of deoxycholic acid16 Jul 2026US 2026/0200967 A1Crystal Pharma, S.A.U.
Most cited
By later US patents
- Synthetic receptors, libraries and uses thereof110US 5,804,563 AThe Trustees of Columbia University in the City of New York · 1998
- Pharmaceutical compositions and methods of transporting compounds across biological membrane93US 5,455,335 AThe Trustees of Princeton University · 1995
- Synthetic receptors81US 6,797,522 B1The Trustees of Columbia University in the City of New York · 2004
- Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments59US 5,512,558 AHoechst Aktiengesellschaft · 1996
- Steroid derived antibiotics59US 6,486,148 B2Brigham Young University · 2002